| 注册
首页|期刊导航|中国药业|"处方精简"干预老年患者多重用药的临床实践

"处方精简"干预老年患者多重用药的临床实践

董燕燕 徐鹏 伍超 车富强 陈震

中国药业2024,Vol.33Issue(14):8-12,5.
中国药业2024,Vol.33Issue(14):8-12,5.DOI:10.3969/j.issn.1006-4931.2024.14.003

"处方精简"干预老年患者多重用药的临床实践

Clinical Practice of Deprescribing Intervention in Polypharmacy for Elderly Patients

董燕燕 1徐鹏 1伍超 2车富强 1陈震1

作者信息

  • 1. 安徽医科大学合肥第三临床学院·安徽省合肥市第三人民医院,安徽 合肥 230022
  • 2. 安徽中医药大学第一附属医院·安徽省中医院,安徽 合肥 230011
  • 折叠

摘要

Abstract

Objective To provide a reference for carrying out the deprescribing-related research and clinical practice in China.Methods The current research status and evidence of deprescribing at home and abroad was elaborated,the main reference tools and process of deprescribing were summarized,and a specific case of hospital pharmacists intervening in polypharmacy for elderly patients based on deprescribing was shared.Results Through a series of deprescribing practices,foreign countries had formulated various processes and guidelines that can guide deprescribing in different situations,while the related research started relatively late in China,but the development trend was good.The domestic and foreign research evidence and pharmacists' clinical practice in deprescribing(the patient was given eight basic medications,and he had a good adherence with five of them;the drugs involving deprescribing included glimepiride,amitriptyline,rabeprazole,estazolam)showed that deprescribing intervention for elderly patients in polypharmacy was safe and feasible.Conclusion Deprescribing is a scientific medication management mode based on evidence-based medicine,which can be as an important measure to intervene in polypharmacy for elderly patients.

关键词

处方精简/老年患者/多重用药/潜在不适当用药/临床实践

Key words

deprescribing/elderly patient/polypharmacy/potentially inappropriate medication/clinical practice

分类

医药卫生

引用本文复制引用

董燕燕,徐鹏,伍超,车富强,陈震.."处方精简"干预老年患者多重用药的临床实践[J].中国药业,2024,33(14):8-12,5.

基金项目

安徽省合肥市第三人民医院科研项目[SYKY201918] ()

安徽中医药大学临床科研项目[2021yfylc11]. ()

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文